Johnson & Johnson's Xian Janssen Pharmaceuticals has inked a dealwith Merck KGaA to launch its diabetes drug Invokana in China, where the drug gained approval in September 2017. Financial details of the deal were not released.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,